Pages that link to "Q38924048"

The following pages link to Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid. (Q38924048):

Displaying 13 items.

• The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition (Q32884479) (← links)
• Golgi post-translational modifications and associated diseases (Q34476104) (← links)
• ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan (Q36919737) (← links)
• A functional splice variant of the human Golgi CMP-sialic acid transporter. (Q38759339) (← links)
• Recent advancements in understanding mammalian O-mannosylation (Q40092479) (← links)
• O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer. (Q42241744) (← links)
• NANS-mediated synthesis of sialic acid is required for brain and skeletal development (Q42696785) (← links)
• A New Mouse Model of Limb-Girdle Muscular Dystrophy Type 2I Homozygous for the Common L276I Mutation Mimicking the Mild Phenotype in Humans (Q50911860) (← links)
• Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1 (Q57475865) (← links)
• Mammalian O-mannosyl glycans: Biochemistry and glycopathology (Q64233103) (← links)
• Disruption of sialic acid metabolism drives tumor growth by augmenting CD8 T cell apoptosis (Q64258056) (← links)
• Physical Principles of Membrane Shape Regulation by the Glycocalyx (Q91769178) (← links)
• Congenital Muscular Dystrophy due to Novel Compound Heterozygote Mutations in POMGNT1 Gene (Q92770935) (← links)